Royalty Pharma plc (NASDAQ:RPRX) IPO
IPO
Priced at US$28.00 a share on Jun 15, 2020.
- Price
- US$28.00 a share
- Shares offered
- 77,681,670 Class A ordinary shares · 60,000,000 from the company and 17,681,670 from selling shareholders
- Offering size
- US$2.18 billion
- Underwriters' option
- Up to 11,652,250 more shares
- Underwriters
- J.P. Morgan, Morgan Stanley, BofA Securities, Goldman Sachs & Co. LLC, Citigroup, UBS Investment Bank, Evercore ISI, Cowen, SunTrust Robinson Humphrey, BBVA, DNB Markets, Scotiabank, TD Securities, Academy Securities, AmeriVet Securities, Blaylock Van, LLC, Cabrera Capital Markets, LLC, R. Seelaus & Co. LLC, Ramirez & Co., Inc., Siebert Williams Shank, Tigress Financial Partners · In the order on the cover
- Shares delivered
- On or about Jun 18, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 13, 2020 |
| Filed publicly | May 22, 2020 |
| Amended 3 times | Newest Jun 11, 2020 |
| Shares registered with an exchange | Jun 15, 2020 |
| Declared effective by the SEC | Jun 15, 2020 |
| Final prospectus, with the price | Jun 17, 2020 |
Filings
From the cover of the final prospectus (424B4) filed Jun 17, 2020